FX Dialysers
FX portfolio
All FX Dialysers have the capacity to remove a broad range of uraemic toxins, effectively retain endotoxins and provide intrinsic biocompatibility.1
Simplified work flows
The FX Dialysers are developed for system compatibility, perfectly fitting into automatic priming procedures with low rinsing volumes and short preparation times. In addition, there is no need to turn any FX Dialyser during the priming procedure. Moreover, the FX Dialysers have a removable label that can easily be attached to patient records, allowing for quick documentation.
Simplified work flows, user-friendly handling and short preparation time support the nursing staff’s daily work, freeing up resources to focus more on patients.
Adding value across the entire life cycle
Fresenius Medical Care has implemented an approach based on the Life Cycle Assessment (LCA) methodology, which follows the structure and requirements of EN ISO 14040/44: 2006:
- Comprehensive assessment of a product’s environmental impact across its full life cycle, from materials supply to manufacturing, distribution, use and final disposal.
- Identification of improvement opportunities through environmentally sound processes, materials and design choices.
Lightweight material is essential for environmental sustainability
The advanced housing material of every FX Dialyzer is made of environmentally friendly and lightweight polypropylene. Due to the advanced material, FX Dialyzers are up to 50% lighter (before treatment) than dialysers made of polycarbonate22
This may result in improved end-of-life management by producing less waste23 and contributing to cost savings.
Improved eco-performance
Across 15 environmental impact categories24, the overall eco-performance of an FX Dialyzer (FX classix 80) is notably better — on average by 42% — compared to a reference dialyser made from polycarbonate (HF 80S).25
FX blue art project
Dialysers are life-saving pieces of medical and technological art. The advanced design of the FX Dialysers adds a dimension that reflects the thought, care and quality that went into its construction. As the most prominent visible characteristic, the color blue of the FX Dialyser caps became the inspiration point for our unique blue art project. We asked artists to interpret the benefits of the FX Dialysers in their own way — be it figurative or abstract, poetic or surreal, two- or three-dimensional — with stunning results. Each artist granted another level of meaning, a unique interpretation or a new perspective to apply to the distinctive functional properties of the FX Dialysers. Warm and sensitive, intellectual and meaningful approaches came to life.
Art gallery
- <p>Urine test</p>
- <p>Blood test</p>
- <p>Urine test</p>
- <p>Imaging</p>
- <p>Kidney biopsy (if needed)</p>
Additional information relating to multiBic or Calrecia can be found in the critical care section of our product information page.
Adverse Events Reporting
Adverse events should be reported. Reporting forms and information can be found at
https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple app store. Adverse events should also be reported to Fresenius Medical Care on 01623 445100.
UK/HEMA/FME/0922/0005 Date of Preparation: November 2022
1 Wagner S. et al., Nephrology Dialysis Transplantation (2017); 32 (3): iii615.
2 Bock A. et al., J Am Soc Nephrol (2013); 24: SA-PO404.
3 Maduell F. et al., Blood Purif. (2014); 37(2): 125-130.
4 Lim P. S. et al., Artif Organs (2017); Nov 27. doi: 10.1111/aor.13011.
5 Schindler R. et al., Clin. Nephrology (2003); 59: 447–454.
6 Weber V. et al., Artif Organs (2004); 28(2): 210-217.
7 Chazot C. et al., Nephron (2015); 129: 269-275.
8 Tsai I.J. et al., Pediatr Nephrol (2014); 29: 111–116.
9 Data from Fresenius Medical Care Deutschland GmbH: Comparison clearance values F8 HPS (effective surface area 1.8 m2) versus FX 8 (effective surface area 1.4 m2).
10 Ronco C., Nissenson A. R., Blood Purif (2001); 19: 347-352.
11 Ronco C. et al., Kidney International (2002); 61 (80): 126-142.
12 Külz M. et al., Nephrol Dial Transplant (2002); 17: 1475-1479.
13 Mandolfo S. et al., The International Journal of Artificial Organs (2003); 26 (2): 113-120.
14 Allard B. et al., Le Pharmacien Hospitalier et Clinicien (2013); 48 (4): 15-21.
15 Shintani H., Biomedical instrumentation & technology (1995); 29 (6): 513–519.
16 Hirata N. et al., Radiation Physics and Chemistry (1995); 46 (3): 377–381.
17 Golli-Bennour E. E. et al., International urology and nephrology (2011); 43 (2): 483–490.
18 Azzabi A. et al., Néphrologie & Thérapeutique (2014); 10 (5): 318.
19 Golli-Bennour E.E et al., World J Nephrol Urol (2017); 6 (1-2): 14-17.
20 da Silva Aquino K. A., INtechOpen (2012); www.intechopen.com/books/gamma-radiation/sterilization-by-gamma-irradiation (27.04.2018).
21 Dawids S., Handlos V. N., Developments in hematology and immunology (1989); 347–368.
22 Unpublished data from Fresenius Medical Care Deutschland GmbH: Internal calculation based on weight measurements before treatment of FX Dialyzers versus F-series dialysers.
23 Unpublished data from Fresenius Medical Care Deutschland GmbH: Internal calculation based on weight measurements of FME FX classix 80 versus FME HF 80S. The typical number of treatments in most clinics is approximately 10,000 per year; this results in about 1,600 kg less waste being produced annually with FX classix 80 when used on FME 5008 CorDiax machine.
24 EC-JRC-IES (2011): ILCD handbook – Recommendations for LCIA in the European context. Source: publications.jrc.ec.europa.eu/repository/handle/JRC61049 (all 15 environmental impact categories with recommendation in table 1 of this ILCD handbook have been evaluated).
25 Unpublished data from Fresenius Medical Care Deutschland GmbH internal study (2018): Comparative life cycle assessment of selected FME dialysers. Eco-performance is always calculated versus baseline product (FME HF 80S); long distance scenario illustrated.